Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the first healthy volunteer in the Phase 1 clinical study of EGL-003, an IL‑2⍺-biased mutein designed to selectively activate Tregs while limiting effector T cell stimulation, as a potential treatment for atopic dermatitis. The open-label, multi-center Phase 1 trial begins with a single ascending dose p...

FPT Software, a subsidiary of Global IT services provider FPT, is positioned as a Major Player in IDC MarketScape: Asia/Pacific (Excluding Japan) Managed Detection and Response Services 2025 Vendor Assessment (Doc # AP52998725). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029338749/en/ This IDC MarketScape evaluates 16 vendors that provide MDR services within the Asia/Pacific (excluding Japan) market. The assessment framework ...